Access provided by
London Metropolitan University
NHS England has committed to reduce the amount of psychotropic medicines being prescribed for people with learning disabilities. Studies suggest the numbers of people with learning disabilities prescribed psychotropic medicines is far higher than numbers with documented mental health diagnoses, for which such medicines should be prescribed. This article examines the reasons why medication is prescribed, best practice, the side effects and the issues that are involved with the withdrawal of psychotropic medicines, in particular antipsychotics, in people with learning disabilities. Learning disability nurses are well placed to review and assist with the withdrawal of antipsychotic medication; they are an integral part of the challenge to reduce prescribing of antipsychotic medicines for people with learning disabilities. They also offer a vital link between healthcare professionals in primary and secondary care.
Learning Disability Practice. 19, 8, 21-25. doi: 10.7748/ldp.2016.e1763
Correspondence Peer reviewThis article has been subject to double-blind review and has been checked for plagiarism using automated software
Conflict of interestNone declared
Received: 29 April 2016
Accepted: 19 August 2016
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more